PPT-ABCS Aspirin Treatment for Secondary and

Primary Prevention ASCVD Jennifer Bannon RN BSN MSHI Table of Contents Objectives Cardiovascular Disease Cardiovascular Disease 2 ABCSAspirin when appropriate Anatomy of a Performance Measure. د. حسين محمد جمعة . اختصاصي الامراض الباطنة . . البورد العربي . كلية طب الموصل . . . . 2011. . . Aspirin. perhaps most popular medicinal agent ever discovered. 30 000 000 . lb. /year sold in the US. Antipyretic (reduces fever). Anti-inflammatory (reduces . swelling suppresses prostaglandin hormone). Thromboembolism. N . Engl. J Med. 2012;366:1959-67. VTE Prevalence. Incidence . of DVT: 48 per 100,000. Incidence of PE: 23 per 100,000. Case-fatality rate. Inpatient: 12%. 1-year: 19%; 3-year: 30%. Evaluating the Risks and Benefits. Most Frequently Used OTC Analgesics. Reasons Why These Drugs Are Widely Used. What Limits the Use of OTC Drugs?. Adverse Effects of OTC Analgesics. Efficacy of Aspirin in Headache. Understandings. Aspirin . Mild . analgesics function by intercepting the pain stimulus at the source, often by interfering with the production of substances that cause pain, swelling, or fever. . Aspirin . The sensation of pain – our ability to perceive pain is one of our best defense mechanisms. . Pain allows us to act in a way that reduces further damage to our bodies. For example, removing the hand from a hot plate or not being able to continue running after pulling a muscle.. No aspirin (n = 7,335) JPPP Primary endpoint (CV death/MI/stroke) for aspirin vs. no aspirin: 2.8% vs. 3.0%, p = 0.54 CV death: 0.86 % vs. 0.78%, p = 0.89 ; nonfatal cerebrovascular disease: 1.65 Original Article Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism Timothy A. Brighton, M.B., B.S., John W. Eikelboom, M.B., B.S., Kristy Mann, M.Biostat., Rebecca Mister, M.Sc., Alexander Gallus, M.B., B.S., Paul Ockelford, M.B., Harry Gibbs, M.B., Wendy Hague, Ph.D., Denis Xavier, M.Sc., Rafael Diaz, M.D., Adrienne Kirby, M.Sc., John Simes, M.D., for the ASPIRE Investigators Therapeutic uses & contraindication. Aspirin . act as an analgesic, antipyretic, Anti-inflammatory also inhibit platelet aggregation & prolongs bleeding time, because of its effect on G.I.T it is contraindicated in peptic . A New Aspirin Option for the High-Risk Patient . Panelists. Program Goals. Case Study. Current Medications. Case Study (cont). Lipid Guidelines for Patients With ASCVD . Secondary Prevention. Treatment of Hypertension in Those With Known Coronary Artery Disease. as salicylic acid and its derivatives e.g. aspirin, and . paracetamol. , . block the transmission of pain from source . i.e. the injured tissue to . brain as they intercept the pain stimulus . at source. . ORIGIN. Pierre . Amarenco. , Hans . Denison. , . Scott R. Evans, Anders . Himmelmann. , Stefan James, Mikael . Knutsson. , . Per . Ladenvall. , Carlos . A. Molina. , . Yongjun. Wang. , S. . Claiborne . 89 non-cardioembolic stroke detected by rapid platelet function analyzer Jose C NAVARRO MD MSc , Annabelle Y LAO MD , Maricar P YUMUL MD , Maria Leticia C ARAULLO MD , Johnny K LOKIN MD , Aleja 50 Corresponding author: L RTICLERef: Ro J Neurol. 2021;20(1)DOI: 10.37897/RJN.2021.1.7listed as the primary causes of death and disability JOLOGY – VOLUME XX, N 51 Aspirin and non-steroidal an